These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34797887)
1. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways. Amirfallah A; Knutsdottir H; Arason A; Hilmarsdottir B; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I PLoS One; 2021; 16(11):e0260327. PubMed ID: 34797887 [TBL] [Abstract][Full Text] [Related]
2. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer. Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189 [TBL] [Abstract][Full Text] [Related]
3. Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis. Mesci A; Huang X; Taeb S; Jahangiri S; Kim Y; Fokas E; Bruce J; Leong HS; Liu SK Br J Cancer; 2017 May; 116(10):1350-1357. PubMed ID: 28419078 [TBL] [Abstract][Full Text] [Related]
4. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506 [TBL] [Abstract][Full Text] [Related]
5. miR-410-3p suppresses breast cancer progression by targeting Snail. Zhang YF; Yu Y; Song WZ; Zhang RM; Jin S; Bai JW; Kang HB; Wang X; Cao XC Oncol Rep; 2016 Jul; 36(1):480-6. PubMed ID: 27221455 [TBL] [Abstract][Full Text] [Related]
6. Cell specific tumor suppressor effect of Hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes. Mohamadzade Z; M Soltani B; Ghaemi Z; Hoseinpour P Int J Biochem Cell Biol; 2021 May; 134():105965. PubMed ID: 33675995 [TBL] [Abstract][Full Text] [Related]
7. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin. Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325 [TBL] [Abstract][Full Text] [Related]
8. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway. Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950 [TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circRNA_002178 silencing retards breast cancer progression via microRNA-328-3p-mediated inhibition of COL1A1. Liu T; Ye P; Ye Y; Lu S; Han B J Cell Mol Med; 2020 Feb; 24(3):2189-2201. PubMed ID: 31957232 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma. Zhao CC; Guo H; Wang Y; Li JH Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Li S; Xu JJ; Zhang QY Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM Front Oncol; 2020; 10():756. PubMed ID: 32509578 [TBL] [Abstract][Full Text] [Related]
13. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling. Xu X; Lv YG; Yan CY; Yi J; Ling R Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway. Fan X; Huang X; Li Z; Ma X J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852 [TBL] [Abstract][Full Text] [Related]
17. MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis. Farré PL; Duca RB; Massillo C; Dalton GN; Graña KD; Gardner K; Lacunza E; De Siervi A Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681793 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669 [TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes. Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704 [TBL] [Abstract][Full Text] [Related]
20. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics. Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]